Implementing an age-friendly model into oncology care: a quality improvement initiative
NCODA Oncology and Hematology Meeting Abstracts · 15.06.2026
DOI: 10.67209/dasy8681 ↗Kurz gefasst
Fachartikel in der Zeitschrift NCODA Oncology and Hematology Meeting Abstracts, online erschienen am 15.06.2026. Verfasst von Heather Duncan. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
According to the United States of America (USA) Census Bureau, the USA population aged 65+ years is expected to nearly double over the next 30 years, from 43.1 million in 2012 to an estimated 83.7 million in 2050. Age-Friendly Care is an initiative of The John A. Hartford Foundation and the Institute for Healthcare Improvement (IHI), in partnership with the American Hospital Association (AHA) and the Catholic Health Associates of the United States (CHA) designed to incorporate health equity into care for our older adults (IHI, 2025). This initiative focuses on assessing and addressing the 4Ms with each older adult both annually and on “significant change in condition”. The 4Ms consist of What Matters, Medications, Mobility, and Mentation (assessing for cognitive decline and depression). Once these 4 areas are assessed, health care providers can guide the patient’s treatment plan based on what matters most to the patient and are alerted to potential issues through focused screening tool use.
Zitieren
APA
Duncan, H. (2026). Implementing an age-friendly model into oncology care: a quality improvement initiative. NCODA Oncology and Hematology Meeting Abstracts. https://doi.org/10.67209/dasy8681
Vancouver
Duncan H. Implementing an age-friendly model into oncology care: a quality improvement initiative. NCODA Oncology and Hematology Meeting Abstracts. 2026. doi:10.67209/dasy8681
BibTeX
@article{Duncan2026,
author = {Duncan, Heather},
title = {Implementing an age-friendly model into oncology care: a quality improvement initiative},
journal = {NCODA Oncology and Hematology Meeting Abstracts},
year = {2026},
doi = {10.67209/dasy8681}
}
EUVIMED